Delivery Order SPE2DB22D3009-SPE2DB25FAQ48
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,544,046 units of Tamsulosin HCl 0.4 mg capsules. The contract has a firm fixed price of $10,292.14 and a completion date of May 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,092.74, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of January 21, 2025. This contract is a task order under a larger Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,118.38, is for the supply of 1,000 units of Tamsulosin Hydrochloride 0.4 mg capsules. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,394.02, is for the supply of Tamsulosin HCL 0.4 mg capsules in 1,000-count quantities. The contract has a period of performance through February 5, 2025 and utilizes a Firm Fixed Price pricing type. This Delivery Order contract is associated with a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,418,131 units of Tamsulosin HCl 0.4 mg capsules. The contract is a firm-fixed price award with a ceiling value of $7,124.76 and an ultimate completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical medications to support military treatment facilities and other federal healthcare programs. This order is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,118.77 firm fixed-price delivery order is for the supply of Tamsulosin HCL 0.4 mg capsules in 1,000-count units. The contract has a completion date of July 22, 2024 and was awarded on July 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,823,091 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $5,949.44 and an ultimate completion date of August 16, 2023. The contract was awarded on August 15, 2023 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,563,731,438 units of Tamsulosin HCL 0.4 mg capsules, with a completion date of February 22, 2024. The potential value of this award is $3,805.29. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) it...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 capsules of Tamsulosin HCl 0.4 mg. The contract has a ceiling value of $10,622.09 and is a firm fixed-price delivery order that will be completed by July 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,326.16 firm-fixed-price delivery order is for the supply of 4,566,280,778 units of Tamsulosin HCL 0.4 mg capsules, with a completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...